- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03037554
The Effects of Lateralized Thermal Sleepwear on Sleep, Skin Temperature and Skin Moisture in Menopausal Women
March 26, 2021 updated by: Paul Glovinsky, Ph.D., St. Peter's Hospital, Albany, NY
The Effects of Sleepwear With Lateralized Thermal Characteristics on Sleep, Proximal Skin Temperature and Sternal Skin Moisture in Menopausal Women
A home-based, sham-controlled, double-blind, crossover study evaluating the effects of wearing sleepwear with lateralized thermal characteristics on subjective and objective sleep measures, proximal skin temperature, and sternal skin moisture in menopausal women complaining of sleep disturbance and vasomotor symptoms.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Sixteen menopausal women who have given informed consent to participate will be medically screened to rule out physiological sleep disorders.
Sleep schedules will be regulated to the average bedtime of a two-week baseline sleep log.
Subjects will undergo two two-night, home-based monitoring phases, one an experimental and one a control condition, separated by a washout period of at least five nights.
The order of conditions will be counterbalanced between subjects in double-blind fashion.
In the experimental condition subjects will wear sleepwear constructed of two fabric types arranged bilaterally, with typical cotton spandex insulating material on one side and specialized conductive material on the other.
In the control condition subjects will wear sleepwear that is similarly lateralized in terms of appearance but constructed with typical cotton spandex insulating material on both sides.
Ambulatory monitoring will include body position, EEG, actigraphy, skin temperature at multiple proximal sites, and sternal skin moisture.
Subjective scales of insomnia severity, menopausal symptoms and sleepwear rating will also be employed.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Albany, New York, United States, 12205
- St. Peter's Sleep Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- At least 12 months since last menstrual period
- Subjective complaint of sleep disturbance, confirmed by Pittsburgh Sleep Quality Index score greater than 5
- Subjective complaint of at least moderate symptoms of menopause, confirmed by modified Kupperman score greater than 15
- Ability to sleep in the left lateral, right lateral and supine positions
Exclusion Criteria:
- Unable to taper off, with health care provider's agreement, hypnotic or sedative medications, hormone replacement therapy, clonidine, gabapentin, or isoflavones and other botanical compounds used to treat vasomotor symptoms of menopause
- Unable to taper to two or fewer caffeinated beverages per day
- Unable to taper to one or fewer alcoholic beverages per day
- Unable to taper off nicotine in any form
- Unable to taper off recreational drugs
- Subjective sleep, based on two-week sleep logs, averaging less than 4.0 or greater than 7.5 hours per night
- Clinical suspicion of obstructive sleep apnea, periodic leg movements or other significant physiological sleep disturbance
- Known skin allergy to silver, cotton, nylon, surgical tape and other adhesives
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lateralized Thermal Sleepwear
For two consecutive nights subjects will wear Sleepwear with Lateralized Thermal Characteristics
|
Subjects will wear sleepwear constructed with insulating fabric on one side and conductive fabric on the other side, arranged bilaterally.
|
Sham Comparator: Sham-Lateralized Sleepwear
For two consecutive nights subjects will wear Sham-Lateralized Sleepwear
|
Subjects will wear sleepwear constructed with two insulating fabrics arranged bilaterally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Sleep Time
Time Frame: Two nights in the experimental condition and two nights in the control condition.
|
Minutes of sleep of any stage, as scored by conventional criteria, across recording period.
|
Two nights in the experimental condition and two nights in the control condition.
|
Wakefulness After Sleep Onset
Time Frame: Two nights in the experimental condition and two nights in the control condition.
|
Minutes of Wakefulness, as scored by conventional criteria, from first epoch of sleep until end of recording period.
|
Two nights in the experimental condition and two nights in the control condition.
|
Minutes of non-rapid eye movement (NREM) Stage 1 Sleep
Time Frame: Two nights in the experimental condition and two nights in the control condition.
|
Minutes of NREM Stage 1 Sleep, as scored by conventional criteria, across recording period.
|
Two nights in the experimental condition and two nights in the control condition.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proximal Skin Temperature
Time Frame: Measurements taken every 90 seconds across two-night experimental and control conditions
|
Thermochron iButton-derived measurements of skin temperature at bilateral Infraclavicular, Lateral Abdominal and Vastus Lateralis sites
|
Measurements taken every 90 seconds across two-night experimental and control conditions
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Position Monitoring
Time Frame: Position sampled every two seconds across two nights in experimental condition and two nights in control condition
|
Sleep position recorded by iPhone-based SomnoPose app
|
Position sampled every two seconds across two nights in experimental condition and two nights in control condition
|
Sternal Skin Moisture
Time Frame: Measurements taken every three minutes across two nights in experimental condition and two nights in control condition
|
Skin humidity at sternum recorded by specialized Thermochron iButton
|
Measurements taken every three minutes across two nights in experimental condition and two nights in control condition
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paul Glovinsky, Ph.D., St. Peter's Sleep Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 21, 2017
Primary Completion (Actual)
March 15, 2020
Study Completion (Actual)
March 15, 2020
Study Registration Dates
First Submitted
January 19, 2017
First Submitted That Met QC Criteria
January 27, 2017
First Posted (Estimate)
January 31, 2017
Study Record Updates
Last Update Posted (Actual)
April 1, 2021
Last Update Submitted That Met QC Criteria
March 26, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Lateralized Thermal Sleepwear
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause Related Conditions
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasRecruitingMenopause Related ConditionsUnited States
-
Wake Forest University Health SciencesWithdrawnMenopause Related Conditions
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation
-
Women's Hormone NetworkNot yet recruitingMenopause | Menopause Related Conditions | Perimenopausal Disorder
-
Semaine HealthCitruslabsCompletedMenopause | Menopause Related Conditions | Perimenopausal DisorderUnited States
-
J3 Bioscience, Inc.Advanced Clinical Research, Inc.; Phil Triolo and Associates LCCompletedPostmenopausal Symptoms | Menopause Related ConditionsUnited States
-
University of Colorado, Colorado SpringsEast Carolina UniversityRecruitingMenopause | Menopause Related Conditions | Menopause SyndromeUnited States
-
National Taiwan University HospitalNational Taiwan University Hospital Beihu BranchRecruiting
Clinical Trials on Sleepwear with Lateralized Thermal Characteristics
-
Cairo UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPancreatic Ductal Adenocarcinoma
-
Wake Forest University Health SciencesTerminatedNon-small Cell Lung CancerUnited States
-
Centre Hospitalier Universitaire, AmiensUnknownAstrocytoma | Ganglioglioma Desmoplastics and InfantileFrance
-
Brugmann University HospitalCompleted
-
Northwestern UniversityAmerican Pain Society; Rosalind Franklin University of Medicine and Science; Insulin...CompletedDiabetic Neuropathy, Painful
-
University of Roma La SapienzaNot yet recruitingKnee Osteoarthritis
-
Federal University of Health Science of Porto AlegreCompletedRange of Motion, ArticularBrazil
-
Boston UniversityBill and Melinda Gates FoundationCompletedPneumonia, Bacterial | Infections, BacterialMalawi
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainSuspendedEstablishing Normative Values for Thermal Detection and Pain Threshold Established by the Psi MethodSmall Fiber NeuropathyBelgium